• Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Log in to your Inderes Free account to see all free content on this page.
Create account

Neola Medical

0.90 SEK

-5.26 %

Less than 1K followers

NEOLA

First North Stockholm

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
-5.26 %
-20.36 %
+5.88 %
-12.10 %
-18.27 %
-59.84 %
-49.36 %
-72.96 %
-83.21 %

Neola Medical operates in the medical technology sector. The company focuses on neonatal care, where it develops medical equipment. Examples of products that the company provides to the healthcare sector include technical monitoring and follow-up of lung capacity in premature infants. In addition to the main product, ancillary products and disposables are offered. The largest operations are found in the Nordic market. Neola Medical was founded in 2016 and is headquartered in Sweden.

Read more
Market cap
112.25M SEK
Turnover
32.84K SEK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%
EPS and dividend
Financial calendar
21.8.
2026

Interim report Q2'26

18.11.
2026

Interim report Q3'26

All
Press releases
3rd party
ShowingAll content types

Revenue and EBIT-%

Revenue K

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Press release6/3/2026, 5:30 AM

Neola Medical to Present at Aktiedagarna: Advancing U.S. Market Preparations Following Positive Clinical Safety Results

Neola Medical
Press release5/20/2026, 9:20 AM

Redeye: Neola Medical (Q1 Review): An undramatic report after an eventful period

Neola Medical
Regulatory press release5/19/2026, 5:00 AM

Neola Medical Q1 Report 2026 – Positive safety results from clinical study in preterm born babies strengthen the path toward market

Neola Medical

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and deep analyses
Premium tools: model portfolio, screener, insider transactions
Premium columns: Guest column, expert insights
Inderes MCP - Inderes data directly into your AI tools
Create account
Regulatory press release4/21/2026, 5:00 AM

Neola Medical Reports Positive Safety Results from First Clinical Pilot Study and Advances Towards Next Phase of Clinical Development

Neola Medical
Press release3/16/2026, 6:05 AM

Neola Medical Completes Enrollment in Swedish Clinical Pilot Study

Neola Medical
Press release2/13/2026, 11:59 AM

Redeye: Neola Medical (Q4 Review): Eyes on upcoming clinical data

Neola Medical
Regulatory press release2/12/2026, 6:00 AM

Neola Medical Q4 Report 2025 – Advancing IP Protection as a Core Strategic Asset across Key Markets

Neola Medical
Press release2/5/2026, 7:00 AM

Neola Medical invites to presentation of the Q4-report 2025

Neola Medical
Press release12/17/2025, 10:40 AM

Neola Medical’s CEO shares recent company highlights in winter 2025 investor letter

Neola Medical
Regulatory press release12/9/2025, 6:00 AM

Neola Medical expands leadership team with appointment of Director Disposable Product Development

Neola Medical
Press release12/2/2025, 6:00 AM

Neola Medical granted U.S. patent for disposable probes, strengthening future revenue model in target market

Neola Medical
Press release11/13/2025, 6:00 AM

Neola Medical granted Patent in China for reducing optical noise in lung monitoring measurements

Neola Medical
Press release11/7/2025, 7:37 AM

Redeye: Neola Medical (Q3 Review) - Revised timeline

Neola Medical
Regulatory press release11/4/2025, 5:57 PM

Neola Medical Q3 Report 2025 – Progressing toward completion of Swedish clinical pilot study and strengthening leadership team

Neola Medical
Regulatory press release11/4/2025, 5:53 PM

Revised Timeline Announced as Clinical Pilot Study Indicates Robust Safety and Need for Optimization of Neola®

Neola Medical
Press release10/16/2025, 6:00 AM

Neola Medical Strengthens Global IP Portfolio with New Patents Granted in both the U.S. and China for Medical Device Neola®

Neola Medical
Press release10/1/2025, 5:00 AM

Neola Medical’s CEO highlights recent progress in autumn 2025 investor letter

Neola Medical
Regulatory press release9/25/2025, 5:20 AM

Neola Medical strengthens leadership team with appointment of Clinical Director

Neola Medical
Press release9/10/2025, 5:00 AM

Neola Medical granted European patent enabling lung monitoring beyond preterm born babies

Neola Medical
Press release8/26/2025, 12:26 PM

Redeye: Neola Medical Q2 - Potential share price trigger incoming

Neola Medical